PHARMCO II ApS: Financial statements 2024
CVR: 25202899
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PHARMCO II ApS (CVR 25202899) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -50,125 and a net result of DKK 7,096,622 compared with DKK 12,970,391 the year before. Equity in the 2024 report amounted to DKK 92,123,913. The solvency ratio was 77%. The company had 77 employees in the financial year.
- Gross Profit
- DKK -50,125
- Profit/Loss
- DKK 7,096,622
- Equity
- DKK 92,123,913
- Total Assets
- DKK 119,598,003
- Employees
- 77
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -50 t. | 7.1 mio. | 92.1 mio. | 77 |
| 2023 | - | -47 t. | 13 mio. | 85.1 mio. | 65 |
| 2022 | - | 0 | -1.7 mio. | 72.1 mio. | 63 |
| 2021 | - | 0 | 4.2 mio. | 73.8 mio. | 49 |
| 2020 | - | -20 t. | 2.8 mio. | 69.7 mio. | 48 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PHARMCO II ApS has published its annual report for 2023. Gross profit came to DKK -47,250, and the net result was DKK 12,970,391.
About PHARMCO II ApS
PHARMCO II ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK -56,000 and a net result of DKK 34,432,000 compared with DKK 7,096,622 the year before. Equity in the 2025 report amounted to DKK 107,079,000.